|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM228446953 |
003 |
DE-627 |
005 |
20231224075927.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2013 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/la400623s
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0761.xml
|
035 |
|
|
|a (DE-627)NLM228446953
|
035 |
|
|
|a (NLM)23777276
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Wang, Longgang
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Reducing the cytotoxity of poly(amidoamine) dendrimers by modification of a single layer of carboxybetaine
|
264 |
|
1 |
|c 2013
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 05.02.2014
|
500 |
|
|
|a Date Revised 16.07.2013
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a The surface primary amines of generation five poly(amido amine) (G5 PAMAM) dendrimer were modified by different amounts of carboxybetaine acrylamide (CBAA). As a result, the fully modified molecules (CBAA-PAMAM-20, obtained from the 20:1 molar ratio of CBAA molecules to amino groups in modification solution) show excellent compatibility with protein and cells. CBAA-PAMAM-20 and fibrinogen (Fg) could coexist in solution without forming aggregation, indicating very weak interaction force between CBAA-PAMAM-20 and fibrinogen. CBAA-PAMAM-20 exhibits almost undetectable hemolytic activity, while other partially modified ones cause severe hemolysis and fibrinogen aggregation. Furthermore, the membrane of human umbilical vascular endothelial cell (HUVEC) remains intact after 24 h incubation with CBAA-PAMAM-20. The cytotoxicity assay of HUVEC cells and KB cells also showed that the CBAA-PAMAM-20 was not cytotoxic up to a 2 mg/mL concentration (>90% cell viability). In short, a thin compact layer of zwitterionic carboxybetaine could reduce the cytotoxicity of PAMAM through minimizing the interaction with protein and cell membranes, which suggest that the carboxybetaine-coated PAMAM could be a useful platform for biocompatible carriers to load contrast agents and drugs
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Biocompatible Materials
|2 NLM
|
650 |
|
7 |
|a Dendrimers
|2 NLM
|
650 |
|
7 |
|a PAMAM Starburst
|2 NLM
|
650 |
|
7 |
|a Proteins
|2 NLM
|
650 |
|
7 |
|a Betaine
|2 NLM
|
650 |
|
7 |
|a 3SCV180C9W
|2 NLM
|
700 |
1 |
|
|a Wang, Zhen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ma, Guanglong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lin, Weifeng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Shengfu
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1992
|g 29(2013), 28 vom: 16. Juli, Seite 8914-21
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:29
|g year:2013
|g number:28
|g day:16
|g month:07
|g pages:8914-21
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/la400623s
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 29
|j 2013
|e 28
|b 16
|c 07
|h 8914-21
|